Jazz Pharmaceuticals (JAZZ) Net Margin (2010 - 2026)
Jazz Pharmaceuticals' quarterly Net Margin came in at 27.42% in Q1 2026, up 3767.0% year-on-year from 0.71% in Q1 2025, and up 61.44% quarter-over-quarter from 16.99% in Q4 2025.
Jazz Pharmaceuticals has reported Net Margin for 16 years, with the latest figure at 27.42% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 3767.0% year-over-year to 27.42%; the trailing twelve-month figure through Mar 2026 stood at 0.67% (down 1122.0% YoY), and the FY2025 full-year result was 8.33%, down 2214.0% from the prior year.
- Net Margin for Q1 2026 stood at 27.42%, up from 16.99% in the prior quarter.
- The five-year high for Net Margin was 27.42% in Q1 2026, with the low at 68.7% in Q2 2025.
- Average Net Margin over 5 years is 3.67%, with a median of 9.35% recorded in 2023.
- Year-over-year, Net Margin surged 5248 bps in 2022 and sank 8516 bps in 2025.
- Tracing JAZZ's Net Margin over 5 years: stood at 24.68% in 2022, then soared by 138 bps to 9.35% in 2023, then jumped by 88 bps to 17.56% in 2024, then slipped by 3 bps to 16.99% in 2025, then soared by 61 bps to 27.42% in 2026.
- The last three Net Margin figures came in at 27.42% (Q1 2026), 16.99% (Q4 2025), and 22.33% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 27.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.42% |
| Dec 31, 2025 | 16.99% |
| Sep 30, 2025 | 22.33% |
| Jun 30, 2025 | -68.70% |
| Mar 31, 2025 | -10.25% |
| Dec 31, 2024 | 17.56% |
| Sep 30, 2024 | 20.41% |
| Jun 30, 2024 | 16.47% |
| Mar 31, 2024 | -1.47% |
| Dec 31, 2023 | 9.35% |
| Sep 30, 2023 | 15.09% |
| Jun 30, 2023 | 11.08% |
| Mar 31, 2023 | 7.89% |
| Dec 31, 2022 | -24.68% |
| Sep 30, 2022 | -1.82% |
| Jun 30, 2022 | 3.98% |
| Mar 31, 2022 | 0.72% |
| Dec 31, 2021 | -3.61% |
| Sep 30, 2021 | -5.92% |
| Jun 30, 2021 | -48.50% |
| Mar 31, 2021 | 19.37% |
| Dec 31, 2020 | 20.14% |
| Sep 30, 2020 | 24.77% |
| Jun 30, 2020 | 20.74% |
| Mar 31, 2020 | -29.55% |
| Dec 31, 2019 | 12.94% |
| Sep 30, 2019 | 19.21% |
| Jun 30, 2019 | 49.19% |
| Mar 31, 2019 | 16.94% |
| Dec 31, 2018 | 33.65% |
| Sep 30, 2018 | 31.92% |
| Jun 30, 2018 | 18.56% |
| Mar 31, 2018 | 10.42% |
| Dec 31, 2017 | 53.30% |
| Sep 30, 2017 | 15.49% |
| Jun 30, 2017 | 26.83% |
| Mar 31, 2017 | 23.05% |
| Dec 31, 2016 | 29.49% |
| Sep 30, 2016 | 24.03% |
| Jun 30, 2016 | 30.04% |
| Mar 31, 2016 | 22.56% |
| Dec 31, 2015 | 24.28% |
| Sep 30, 2015 | 25.80% |
| Jun 30, 2015 | 26.40% |
| Mar 31, 2015 | 22.86% |
| Dec 31, 2014 | 24.87% |
| Sep 30, 2014 | 8.40% |
| Jun 30, 2014 | 14.97% |
| Mar 31, 2014 | -37.92% |
| Dec 31, 2012 | 18.70% |
| Sep 30, 2012 | -0.22% |
| Jun 30, 2012 | -3.19% |
| Mar 31, 2012 | -2.49% |
| Jun 30, 2011 | 52.32% |
| Mar 31, 2011 | 42.90% |
| Dec 31, 2010 | 16.01% |
| Sep 30, 2010 | 18.07% |
| Jun 30, 2010 | 16.00% |